National gonorrhea therapy monitoring study: treatment results. 1976

R E Kaufman, and R E Johnson, and H W Jaffe, and C Thornsberry, and G H Reynolds, and P J Wiesner

To monitor the efficacy of the 1972 United States Public Health Service recommended treatment regimens for uncomplicated gonorrhea, we studied 9008 patients who were randomly assigned either to aqueous procaine penicillin G, 4.8 million units intramuscularly plus 1 g of oral probenecid, or to one of the three other recommended regimens. Among the 3871 patients re-examined within three to seven days after therapy, the penicillin-probenecid regimen was successful in 96.8 per cent, whereas the cure rates of the ampicillin-probenecid, tetracycline, and spectinomycin regimens were 92.8, 96.2, and 94.8 per cent, respectively. In clinics comparing the regimens, penicillin G-probenecid was as effective as tetracycline, but more effective than ampicillin-probenecid (P less than 0.05) and spectinomycin (P less than 0.01). However, in patients re-examined three to 14 days after treatment, only the ampicillin-probenecid regimen was significantly less effective than penicillin probenecid (P less than 0.01). Despite these differences in results, all four regimens recommended by the Public Health Service provided effective therapy for uncomplicated gonorrhea.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008297 Male Males
D010402 Penicillin G Procaine Semisynthetic antibiotic prepared by combining penicillin G with PROCAINE. Benzylpenicillin Procaine,Jenacillin,Procaine Penicillin,G Procaine, Penicillin,Penicillin, Procaine,Procaine, Benzylpenicillin,Procaine, Penicillin G
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006069 Gonorrhea Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879. Neisseria gonorrhoeae Infection

Related Publications

R E Kaufman, and R E Johnson, and H W Jaffe, and C Thornsberry, and G H Reynolds, and P J Wiesner
September 1976, Journal of the American Venereal Disease Association,
R E Kaufman, and R E Johnson, and H W Jaffe, and C Thornsberry, and G H Reynolds, and P J Wiesner
January 1979, Sexually transmitted diseases,
R E Kaufman, and R E Johnson, and H W Jaffe, and C Thornsberry, and G H Reynolds, and P J Wiesner
January 1979, Sexually transmitted diseases,
R E Kaufman, and R E Johnson, and H W Jaffe, and C Thornsberry, and G H Reynolds, and P J Wiesner
October 1969, Lakartidningen,
R E Kaufman, and R E Johnson, and H W Jaffe, and C Thornsberry, and G H Reynolds, and P J Wiesner
April 1974, Zeitschrift fur Allgemeinmedizin,
R E Kaufman, and R E Johnson, and H W Jaffe, and C Thornsberry, and G H Reynolds, and P J Wiesner
November 1975, Dermatologische Monatschrift,
R E Kaufman, and R E Johnson, and H W Jaffe, and C Thornsberry, and G H Reynolds, and P J Wiesner
January 1972, Przeglad dermatologiczny,
R E Kaufman, and R E Johnson, and H W Jaffe, and C Thornsberry, and G H Reynolds, and P J Wiesner
January 1950, Vestnik venerologii i dermatologii,
R E Kaufman, and R E Johnson, and H W Jaffe, and C Thornsberry, and G H Reynolds, and P J Wiesner
January 1946, Duodecim; laaketieteellinen aikakauskirja,
R E Kaufman, and R E Johnson, and H W Jaffe, and C Thornsberry, and G H Reynolds, and P J Wiesner
January 1981, Przeglad dermatologiczny,
Copied contents to your clipboard!